Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CALYPTE BIOMEDICAL CORP | Financial_Report.xls |
| 10-Q - FORM 10-Q - CALYPTE BIOMEDICAL CORP | cbc_10q-093012.htm |
| EX-31.1 - EXHIBIT 31.1 - CALYPTE BIOMEDICAL CORP | ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - CALYPTE BIOMEDICAL CORP | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - CALYPTE BIOMEDICAL CORP | ex31-2.htm |
Exhibit 32.2
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of Calypte Biomedical Corporation (the “Company”) for the quarter ended September 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
December 31, 2012
/s/ Kartlos Edilashvili
Kartlos Edilashvili
Vice President and Chief Financial Officer (Principal Financial Officer)